Description

Serocvel XR (quetiapine) tablets with prolonged release 50 mg. №60

Ingredients

Active ingredient: Quetiapine fumarate 50 mg.
Other ingredients: lactose monohydrate, microcrystalline cellulose, hypromellose, and magnesium stearate.

Dosage

Recommended dosage: The usual starting dose is 50 mg once daily at bedtime. Dosage may be adjusted based on individual response. Do not exceed 300 mg per day.

Indications

Serocvel XR tablets are indicated for the treatment of schizophrenia and bipolar disorder. It helps to stabilize mood and reduce hallucinations and delusions.

Contraindications

Do not use Serocvel XR if you are allergic to quetiapine or any other ingredients in the product. It is contraindicated in patients with a history of hypersensitivity reactions.

Directions

Take Serocvel XR exactly as prescribed by your healthcare provider. Swallow the tablet whole with a full glass of water. Do not crush, chew, or break the tablet.

Scientific Evidence

Quetiapine, the active ingredient in Serocvel XR, has been extensively studied for its efficacy in treating schizophrenia and bipolar disorder. Research published in the Journal of Clinical Psychiatry has shown that quetiapine is effective in reducing symptoms of acute mania associated with bipolar disorder. Additionally, a meta-analysis published in the Journal of Clinical Psychopharmacology demonstrated the efficacy of quetiapine in the treatment of schizophrenia.

Additional Information

It is important to follow your healthcare provider’s instructions carefully when taking Serocvel XR. This medication may cause drowsiness, so avoid driving or operating machinery until you know how it affects you. Contact your doctor immediately if you experience any unusual changes in mood or behavior while taking this medication.

Quetiapine, the active ingredient in Serocvel XR, acts as an antagonist at various neurotransmitter receptors in the brain, including serotonin and dopamine receptors. By modulating the activity of these neurotransmitters, quetiapine helps to restore the balance of chemicals in the brain, reducing symptoms of psychosis and mood disturbances.

Clinical trials have shown that Serocvel XR is well-tolerated and effective in the long-term management of schizophrenia and bipolar disorder. A study published in the Journal of Clinical Psychopharmacology found that quetiapine extended-release formulations, like Serocvel XR, were associated with a lower risk of relapse compared to placebo, highlighting its importance in the maintenance treatment of these conditions.